OTCMKTS:NICXF Nicox (NICXF) Stock Price, News & Analysis $0.30 0.00 (0.00%) As of 11/6/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Nicox Stock (OTCMKTS:NICXF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nicox alerts:Sign Up Key Stats Today's Range$0.30▼$0.3050-Day Range$0.30▼$0.3052-Week Range$0.25▼$0.30VolumeN/AAverage VolumeN/AMarket Capitalization$20.68 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Nicox S.A. is a French ophthalmic pharmaceutical company focused on the research and development of therapies for eye diseases. The company’s drug candidates are based primarily on its proprietary nitric oxide-donating research platform, which is designed to address mechanisms involved in conditions such as glaucoma and other diseases affecting the ocular surface. Nicox’s principal development program is NCX 470, a nitric oxide-donating prostaglandin analog being evaluated for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension. The company has also developed ophthalmic treatments for conditions including dry eye disease and has pursued research into additional eye-care applications. The company previously discovered and developed latanoprostene bunod, a nitric oxide-donating glaucoma treatment marketed in the United States by Bausch + Lomb under the brand name VYZULTA. Nicox is headquartered in Sophia Antipolis, France, and its research and development activities are directed toward international ophthalmology markets.AI Generated. May Contain Errors. Read More Receive NICXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nicox and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NICXF Stock News HeadlinesNicox H1 Loss Narrows On Kowa Milestone, Lower CostsOctober 30, 2026 | rttnews.comNicox Narrows Loss, Extends Cash Runway as NCX 470 Nears Key Regulatory MilestonesOctober 30, 2026 | tipranks.comI'm handing you this stock todayElon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.November 11 at 1:00 AM | Behind the Markets (Ad)NICOX SA: Data on Nicox's NCX 470 to be presented at AAOpt Annual Meeting 2026September 16, 2026 | finanznachrichten.deNicox to Present Phase 3 NCX 470 Glaucoma Data at AAOpt 2026September 16, 2026 | tipranks.comNicox Extends Cash Runway as NCX 470 Nears Key Regulatory MilestonesSeptember 2, 2026 | tipranks.comNicox Announces Extension of Cash RunwaySeptember 2, 2026 | markets.businessinsider.comNicox Announces April 2027 PDUFA Date for NCX 470 in GlaucomaAugust 27, 2026 | markets.businessinsider.comSee More Headlines NICXF Stock Analysis - Frequently Asked Questions How have NICXF shares performed this year? Nicox's stock was trading at $0.30 at the beginning of 2026. Since then, NICXF shares have increased by 0.0% and is now trading at $0.30. How do I buy shares of Nicox? Shares of NICXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nicox own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nicox investors own include Mirati Therapeutics (MRTX), Tesla (TSLA), Verizon Communications (VZ), ExxonMobil (XOM), Allergy Therapeutics (AGY), Arch Capital Group (ACGL) and Ameris Bancorp (ABCB). Company Calendar Today11/11/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:NICXF Previous SymbolNASDAQ:NICXF CIKN/A Webwww.nicox.com Phone(349) 724-5300Fax33-4-97-24-53-99Employees28Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$3.59 million Price / Sales5.76 Cash FlowN/A Price / Cash FlowN/A Book Value$0.05 per share Price / Book6.00Miscellaneous Outstanding Shares68,920,000Free FloatN/AMarket Cap$20.68 million OptionableNot Optionable Beta0.01 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:NICXF) was last updated on 11/6/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nicox SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Nicox With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
